Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Belgravia Hartford Capital Inc C.BLGV

Alternate Symbol(s):  BLGVF

Belgravia Hartford Capital Inc. is a Canada-based investment holding company focused on growing its assets and holdings and increasing its net asset value (NAV). It invests in a portfolio of private and public companies. It takes a multi-sector investment approach, with emphasis on the resources and commodities sectors. The Company's investments are considered high-risk holdings, and it may expose shareholders to significant volatility and losses. It operates in three core business divisions: incubation, investments, and royalty & management services. The incubation division helps develop new companies in specific sectors. The Investments division, Belgravia Holdings, provides merchant banking services and invests in a portfolio of private and public companies with a focus on resources, technology, and healthcare. The Royalty and Management Services division has developed a targeted royalty and fee income model and provides services to support the development of early-stage companies.


CSE:BLGV - Post by User

Post by orebody007on Jun 20, 2012 4:22pm
199 Views
Post# 20036337

lets comparison shop...

lets comparison shop...

this is my take on comparing Sirius Minerals (SXX:London) to IC Potash (ICP:Toronto)

Sirius has 1.339 billion shares issued with a market cap of 241,000,000 GBP = $386,000,000 CDN https://www.iii.co.uk/investment/detail?code=cotn:SXX.L&display=fundamentals&it=le

ICP has 152 million shares issued, trading at 77 cents, resulting in a market cap of $117,000,000 CDN.

Sirius' primary development, York Potash, aims to exploit a large polyhalite resource base and produce a mix of sulphate of potash (SOP), epsomite, and gypsum.

York Potash will be developed in two stages: phase one will produce 1.4mtpa of SOP with first production in 2017 while phase two may add 2.7mtpa of SOP starting in 2020.

Big funding hurdles:

Phase one of York Potash should cost $2.7b while phase two will cost $3.3b.

Valuation/Risks

Should Sirius secure approvals and outside funding for York Potash, Jefferies see substantial upside potential to NPV-based fair value.

Jefferies' analyst has a 12-month price target of 25p implies 0.7x base case NPV.

Blue-sky value of $1.9b implies 86p per share.

IC Potash (ICP) is trading at a startling discount to Sirius Minerals (SXX:LN) taking into account Sirius’ concerns re:

$2.7bn (£1.68bn) capex for phase One, ICP's development capex is $706 million, which is extremely low relative to most junior potash projects.

As York Potash is located in a UK national park, the company's ability to secure regulatory approvals for mine, pipeline, and plant development is a concern.

Sirius still has to secure and sign offtakes

Sirius needs to progress toward confirming a JORC resource base and mine development plan, and securing outside funding and governmental approvals definitive resource statement and the completion of a PFS/JORC.

It is envisaged that Phase I capital costs will amount to $2.7bn (£1.68bn) and would allow Sirius to extract and process 5m tonnes of polyhalite ore, which, in turn, would produce 1.4m tonnes of sulphate of potash (SOP).

The next stage of development would ramp up annual production of SOP to 4.1m tonnes by 2024, and is expected to cost an additional $3.3bn.

ICP is squarely in the pole position in the race to develop low cost unconventional SOP supply with demonstrated ability of ICP management to advance and de-risk the project in a challenging market and the Yara partnership is transformational and the first of its kind in the junior potash development space.

Yara International ASA, the world’s largest distributor of plant nutrients made a strategic investment of $40 million into IC Potash and entered into an off-take agreement that guarantees the sale of 30% of ICP's production on a take or pay basis. The term of the off-take will begin upon the commencement of commercial production for a period of 15 years and will automatically extend every five years thereafter unless either party elects not to extend.

Yara paid $1.32 a share for 30.1-million ICP shares resulting in Yara owning 19.9% of the issued and outstanding common shares of ICP on a non-diluted basis.

All products will be sold to Yara based on market prices. Yara's ICP shares are subject to a 24 month lock-up or until all financing to complete construction is secured.

Yara is the ideal partner for ICP with a strong distribution network for potash products. Yara has a market cap of $13.5 Billion, revenues of $14 Billion, and EBITDA of $3 billion. The company has operations in 50 countries and annually distributes 20 million tons of fertilizer products into 150 countries.

Yara and ICP continue discussions about forming a joint marketing company to distribute products cooperatively. This partnership could result in the leading global supplier of Sulphate of Potash.

This partnership is transformational and the first of its kind in the junior potash development space. With Yara as a financial and commercial partner, this validates ICP as the world's leading potash development company and has set the precedent for all other potash development companies.

Post transaction, ICP has retained 100% of the project level equity allowing ICP to enter into additional JVs at the NPV of the project closer to production (current NPV of $1.3 Billion as of the release of the prefeasibility study). Selling 25% of project equity for +$250 million is all the equity capital required to build the project, based on development capex of $706 million, which is low relative to most junior potash projects.

Upon reaching production, ICP will generate $440 million of revenue and $315 million of EBITDA based on current market prices. This means at an 8x EBITDA multiple, ICP could obtain a valuation of more than $2.5 billion dollars.

Bullboard Posts